Smart dosing may help patients wake faster after anesthesia
NCT ID NCT07675850
First seen Jun 30, 2026 · Last updated Jul 01, 2026 · Updated 1 time
Summary
This trial compares a personalized dosing method for the sedative remimazolam to standard weight-based dosing in adults having non-cardiac surgery. The goal is to see if the personalized approach helps patients wake up faster and reduces drug buildup. Participants are randomly assigned to either dosing method, and their depth of anesthesia is monitored throughout surgery.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- remimazolam
- What this could lead to
- If successful, this approach could help patients wake up faster after anesthesia and reduce drug side effects.
- What could go wrong
- This is a small, early-phase trial, so results may not apply to all patients or surgeries. The model may not work better than standard dosing.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PHARMACOKINETICS AND PHARMACODYNAMICS are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Seoul National University Hospital
Seoul, Jongno-gu, 03080, South Korea
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new sedative combo make Children's gastroscopy safer?
- Could a single injection stop post-surgery delirium in children?
- Study aims to Fine-Tune antibiotic dosing for ICU patients
- Could a safer sedative shield kidneys during major abdominal surgery?
- Push-Button sedation: could patients control their own calm during surgery?
- Obesity and antibiotics: study seeks safer dosing